These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 26282097)

  • 41. Interval- and cycle-dependent combined effect of STING agonist loaded lipid nanoparticles and a PD-1 antibody.
    Khalifa AM; Nakamura T; Sato Y; Sato T; Hyodo M; Hayakawa Y; Harashima H
    Int J Pharm; 2022 Aug; 624():122034. PubMed ID: 35863595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of natural killer cell-dependent antitumor immunity by the Autographa californica multiple nuclear polyhedrosis virus.
    Kitajima M; Abe T; Miyano-Kurosaki N; Taniguchi M; Nakayama T; Takaku H
    Mol Ther; 2008 Feb; 16(2):261-8. PubMed ID: 18059370
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.
    Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
    Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of Th1/Th2 Bias of STING Agonists Coated on Microneedles for Possible Use in Skin Allergen Immunotherapy.
    Shakya AK; Lee CH; Uddin MJ; Gill HS
    Mol Pharm; 2018 Nov; 15(11):5437-5443. PubMed ID: 30299105
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An IL-12/Shh-C domain fusion protein-based IL-12 autocrine loop for sustained natural killer cell activation.
    Zhu L; Zhao Z; Wei Y; Marcotte W; Wagner TE; Yu X
    Int J Oncol; 2012 Aug; 41(2):661-9. PubMed ID: 22581115
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microparticle Delivery of a STING Agonist Enables Indirect Activation of NK Cells by Antigen-Presenting Cells.
    Watkins-Schulz R; Batty CJ; Stiepel RT; Schmidt ME; Sandor AM; Chou WC; Ainslie KM; Bachelder EM; Ting JP
    Mol Pharm; 2022 Sep; 19(9):3125-3138. PubMed ID: 35913984
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of STING stimulation on macrophages: STING agonists polarize into "classically" or "alternatively" activated macrophages?
    Ohkuri T; Kosaka A; Nagato T; Kobayashi H
    Hum Vaccin Immunother; 2018 Feb; 14(2):285-287. PubMed ID: 29064738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Control of STING Agonistic/Antagonistic Activity Using Amine-Skeleton-Based c-di-GMP Analogues.
    Yanase Y; Tsuji G; Nakamura M; Shibata N; Demizu Y
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The structural basis for the sensing and binding of cyclic di-GMP by STING.
    Huang YH; Liu XY; Du XX; Jiang ZF; Su XD
    Nat Struct Mol Biol; 2012 Jun; 19(7):728-30. PubMed ID: 22728659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of in vivo fate of STING agonist-loaded lipid nanoparticles on antitumor immunity.
    Endo R; Ueda T; Nagaoki T; Shima N; Sato Y; Harashima H; Nakamura T
    J Control Release; 2024 Aug; 372():609-618. PubMed ID: 38942082
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In Vivo Synthesis of Cyclic-di-GMP Using a Recombinant Adenovirus Preferentially Improves Adaptive Immune Responses against Extracellular Antigens.
    Alyaqoub FS; Aldhamen YA; Koestler BJ; Bruger EL; Seregin SS; Pereira-Hicks C; Godbehere S; Waters CM; Amalfitano A
    J Immunol; 2016 Feb; 196(4):1741-52. PubMed ID: 26792800
    [TBL] [Abstract][Full Text] [Related]  

  • 52. INAM plays a critical role in IFN-γ production by NK cells interacting with polyinosinic-polycytidylic acid-stimulated accessory cells.
    Kasamatsu J; Azuma M; Oshiumi H; Morioka Y; Okabe M; Ebihara T; Matsumoto M; Seya T
    J Immunol; 2014 Nov; 193(10):5199-207. PubMed ID: 25320282
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
    Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
    J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antitumor activity of the Korean mistletoe lectin is attributed to activation of macrophages and NK cells.
    Yoon TJ; Yoo YC; Kang TB; Song SK; Lee KB; Her E; Song KS; Kim JB
    Arch Pharm Res; 2003 Oct; 26(10):861-7. PubMed ID: 14609136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting STING with cyclic di-GMP greatly augmented immune responses of glycopeptide cancer vaccines.
    Wu JJ; Li WH; Chen PG; Zhang BD; Hu HG; Li QQ; Zhao L; Chen YX; Zhao YF; Li YM
    Chem Commun (Camb); 2018 Aug; 54(69):9655-9658. PubMed ID: 30101273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. STING in tumor and host cells cooperatively work for NK cell-mediated tumor growth retardation.
    Takashima K; Takeda Y; Oshiumi H; Shime H; Okabe M; Ikawa M; Matsumoto M; Seya T
    Biochem Biophys Res Commun; 2016 Sep; 478(4):1764-71. PubMed ID: 27608599
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants.
    Hanson MC; Crespo MP; Abraham W; Moynihan KD; Szeto GL; Chen SH; Melo MB; Mueller S; Irvine DJ
    J Clin Invest; 2015 Jun; 125(6):2532-46. PubMed ID: 25938786
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microvessel origin and distribution in pulmonary metastases of B16 melanoma: implication for adoptive immunotherapy.
    Nannmark U; Johansson BR; Bryant JL; Unger ML; Hokland ME; Goldfarb RH; Basse PH
    Cancer Res; 1995 Oct; 55(20):4627-32. PubMed ID: 7553640
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunization with interleukin-2/interferon-gamma double cytokine-secreting allogeneic fibroblasts prolongs the survival of mice with melanoma.
    Kim TS; Xu WS; Sun T; Cohen EP
    Melanoma Res; 1995 Aug; 5(4):217-27. PubMed ID: 7496156
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination.
    Kim A; Noh YW; Kim KD; Jang YS; Choe YK; Lim JS
    Exp Mol Med; 2004 Oct; 36(5):428-43. PubMed ID: 15557815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.